These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18319309)

  • 1. Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement.
    Kublickiene K; Fu XD; Svedas E; Landgren BM; Genazzani AR; Simoncini T
    J Clin Endocrinol Metab; 2008 May; 93(5):1874-83. PubMed ID: 18319309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women.
    Kawano H; Motoyama T; Hirai N; Yoshimura T; Kugiyama K; Ogawa H; Okamura H; Yasue H
    Am J Cardiol; 2001 Jan; 87(2):238-40, A9. PubMed ID: 11152852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dienogest on estrogen-induced nitric oxide production in human umbilical vein endothelial cells and endothelium-dependent vasodilatation in postmenopausal women.
    Henmi N; Takahashi K; Amita M; Takata K; Ohta T; Tsutsumi S; Takahashi T; Kurachi H
    Menopause; 2010; 17(3):615-21. PubMed ID: 20386344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin.
    Fu XD; Flamini M; Sanchez AM; Goglia L; Giretti MS; Genazzani AR; Simoncini T
    Mol Hum Reprod; 2008 Apr; 14(4):225-34. PubMed ID: 18308736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small artery endothelial dysfunction in postmenopausal women: in vitro function, morphology, and modification by estrogen and selective estrogen receptor modulators.
    Kublickiene K; Svedas E; Landgren BM; Crisby M; Nahar N; Nisell H; Poston L
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6113-22. PubMed ID: 16131583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
    Pedersen NG; Pedersen SH; Dalsgaard T; Lund CO; Nilas L; Ottesen B
    Maturitas; 2004 Dec; 49(4):304-14. PubMed ID: 15531126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.
    Yeboah J; Reboussin DM; Waters D; Kowalchuk G; Herrington DM
    Am Heart J; 2007 Mar; 153(3):439-44. PubMed ID: 17307425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiles of progestogen effects in the postmenopausal breast.
    Wood CE; Register TC; Cline JM
    Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hot flushes on cardiovascular autonomic responsiveness: a randomized controlled trial on hormone therapy.
    Hautamäki H; Haapalahti P; Piirilä P; Tuomikoski P; Sovijärvi A; Ylikorkala O; Mikkola TS
    Maturitas; 2012 Jul; 72(3):243-8. PubMed ID: 22537767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative pharmacokinetic study of micronized estradiol valerate administered alone and in combination with medroxyprogesterone acetate in postmenopausal women.
    Saavedra I; León J; Prado J; Sánchez MP; López F; Gaete L
    Ther Drug Monit; 2004 Oct; 26(5):482-5. PubMed ID: 15385829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of transdermal estradiol with and without medroxyprogesterone acetate.
    Pang SC; Greendale GA; Cedars MI; Gambone JC; Lozano K; Eggena P; Judd HL
    Fertil Steril; 1993 Jan; 59(1):76-82. PubMed ID: 8419226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
    Silvestri A; Gambacciani M; Vitale C; Monteleone P; Ciaponi M; Fini M; Genazzani AR; Mercuro G; Rosano GM
    Maturitas; 2005 Apr; 50(4):305-11. PubMed ID: 15780531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Kimura M; Chayama K; Ohama K
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4634-41. PubMed ID: 12364448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
    Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key role of estrogens and endothelial estrogen receptor α in blood flow-mediated remodeling of resistance arteries.
    Tarhouni K; Guihot AL; Freidja ML; Toutain B; Henrion B; Baufreton C; Pinaud F; Procaccio V; Grimaud L; Ayer A; Loufrani L; Lenfant F; Arnal JF; Henrion D
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):605-11. PubMed ID: 23288162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
    Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.